Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abbott Laboratories (NY: ABT ) 112.73 +0.12 (+0.11%) Official Closing Price Updated: 7:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Abbott Laboratories < Previous 1 2 3 4 5 6 7 8 9 ... 38 39 Next > Navigating 6 Analyst Ratings For Abbott Laboratories Today 14:00 EDT Via Benzinga 2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off September 25, 2024 These dividend players could lift your portfolio no matter what the market is doing. Via The Motley Fool Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst September 19, 2024 Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation. Via Benzinga This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday September 19, 2024 Via Benzinga 20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates September 18, 2024 Investors are anticipating the first cut to the federal funds rate in over four years at the September FOMC meeting. The market is divided on the magnitude of the cut, which could trigger significant... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors. September 11, 2024 Is ABBOTT LABORATORIES (NYSE:ABT) a Strong Candidate for Quality Investing? Via Chartmill Looking Into Abbott Laboratories's Recent Short Interest August 29, 2024 Via Benzinga Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns September 17, 2024 These reliable dividend stocks are great buys, with shares still near the bottom of long-term ranges and accelerating growth expected in 2025. Via MarketBeat Topics Economy Exposures Economy Interest Rates Can AbbVie Regain Its Status As a Top Dividend Growth Stock? September 16, 2024 The dividend growth powerhouse is turning the corner. Via The Motley Fool Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy? September 16, 2024 The company continues to flex its innovative muscles. Via The Motley Fool 3 Stocks to Buy and Hold Forever September 14, 2024 These stocks are built for the long run. Via The Motley Fool 3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold September 13, 2024 These stocks have increased their payouts for decades. Via The Motley Fool Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) August 22, 2024 Via Benzinga 2 Stocks That Are Passive Income Machines to Buy and Hold Forever September 11, 2024 You can take these dividends straight to the bank. Via The Motley Fool Medtronic Stock: Growth On Rise of the Cardiovascular Machines September 09, 2024 Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases Via MarketBeat Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System September 05, 2024 Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues. Via Benzinga Topics Product Recall Exposures Legal Product Safety Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device September 05, 2024 The companies are now duking it out for a new population of CGM users. Via Investor's Business Daily 3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever August 30, 2024 These three have secure core businesses, plus multiple paths to grow. Via The Motley Fool Patchy But Still Bullish September 02, 2024 Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations. Via Talk Markets Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain August 26, 2024 Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing... Via Benzinga Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients August 26, 2024 DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo... Via Benzinga Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back? August 26, 2024 The company is upbeat on its upcoming Stelo launch. The CGM is geared to people who don't use insulin. Via Investor's Business Daily This Is Great News for Medtronic, but Is It Time to Buy the Stock? August 26, 2024 This MedTech leader is back on track with profitable growth. Via The Motley Fool Donald Trump Owns These 21 Dividend Kings. Should You? August 26, 2024 Some of Trump's Dividend Kings deserve a crown more than others. Via The Motley Fool Topics Government Exposures Political 3 Unstoppable Dividend Stocks to Buy Right Now August 25, 2024 These stocks are the A-team for income investors. Via The Motley Fool Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally August 23, 2024 Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance. Via MarketBeat Exposures Product Safety Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades' August 22, 2024 Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Management. Via Benzinga Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts. August 17, 2024 These stocks pay above-average yields, and their dividend income could rise higher in the future. Via The Motley Fool Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108? August 12, 2024 An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver. Via The Motley Fool 3 Stocks Retirees Should Absolutely Love August 10, 2024 All of these stocks can provide steady income to retired investors. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 38 39 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.